Free Trial
NYSE:OSTX

OS Therapies (OSTX) Stock Price, News & Analysis

OS Therapies logo
$2.02 +0.03 (+1.51%)
Closing price 04:00 PM Eastern
Extended Trading
$2.08 +0.06 (+3.22%)
As of 04:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About OS Therapies Stock (NYSE:OSTX)

Advanced

Key Stats

Today's Range
$2.00
$2.06
50-Day Range
$1.67
$2.50
52-Week Range
$1.12
$7.00
Volume
225,442 shs
Average Volume
696,968 shs
Market Capitalization
$63.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.00
Consensus Rating
Buy

Company Overview

OS Therapies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
62nd Percentile Overall Score

OSTX MarketRank™: 

OS Therapies scored higher than 62% of companies evaluated by MarketBeat, and ranked 467th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    OS Therapies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Upside Potential

    OS Therapies has a consensus price target of $18.00, representing about 782.4% upside from its current price of $2.04.

  • Amount of Analyst Coverage

    OS Therapies has only been the subject of 1 research reports in the past 90 days.

  • Read more about OS Therapies' stock forecast and price target.
  • Earnings Growth

    Earnings for OS Therapies are expected to grow in the coming year, from ($0.64) to ($0.22) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of OS Therapies is -2.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of OS Therapies is -2.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    3.01% of the float of OS Therapies has been sold short.
  • Short Interest Ratio / Days to Cover

    OS Therapies has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in OS Therapies has recently decreased by 5.28%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    OS Therapies does not currently pay a dividend.

  • Dividend Growth

    OS Therapies does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.01% of the float of OS Therapies has been sold short.
  • Short Interest Ratio / Days to Cover

    OS Therapies has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in OS Therapies has recently decreased by 5.28%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    OS Therapies has a news sentiment score of 0.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.53 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for OS Therapies this week, compared to 2 articles on an average week.
  • Search Interest

    24 people have searched for OSTX on MarketBeat in the last 30 days. This is an increase of 9% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added OS Therapies to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, OS Therapies insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.30% of the stock of OS Therapies is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about OS Therapies' insider trading history.
Receive OSTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OS Therapies and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

OSTX Stock News Headlines

D. Boral Capital Reaffirms Buy Rating for OS Therapies (NYSE:OSTX)
Nvidia Times 1,000,000
Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 trillion calculations per second. Elon Musk and Nvidia’s Jensen Huang are now teaming up to deploy one million of these chips inside what could become the most advanced AI machine on the planet. But according to James Altucher, the real opportunity isn’t in Tesla or Nvidia. He’s uncovered a little-known company that Musk, Nvidia, and even 98% of the Fortune 500 already rely on to make AI 2.0 possible. Nvidia’s CEO has even called this company “essential” to their expansion.tc pixel
OS Therapies Files Prospectus for Stock Resale
OS Therapies Raises $3.7M for OST-HER2 Launch
OS Therapies Ends Equity Agreement with Square Gate
See More Headlines

OSTX Stock Analysis - Frequently Asked Questions

OS Therapies' stock was trading at $4.28 at the beginning of 2025. Since then, OSTX stock has decreased by 52.3% and is now trading at $2.04.

OS Therapies (OSTX) raised $8 million in an initial public offering (IPO) on Thursday, August 1st 2024. The company issued 2,000,000 shares at a price of $4.00 per share. Brookline Capital Markets (Division of Arcadia Securities LLC) acted as the underwriter for the IPO.

Shares of OSTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that OS Therapies investors own include AST SpaceMobile (ASTS), Energy Transfer (ET), Black Stone Minerals (BSM), Kinder Morgan (KMI), Main Street Capital (MAIN), Atlas Energy Solutions (AESI) and Chevron (CVX).

Company Calendar

Today
10/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:OSTX
Previous Symbol
NYSE:OSTX
CIK
1795091
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
2018

Price Target and Rating

High Price Target
$20.00
Low Price Target
$15.00
Potential Upside/Downside
+804.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.79)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.79 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-569.57%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.76
Quick Ratio
0.76

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
31,645,000
Free Float
N/A
Market Cap
$62.97 million
Optionable
N/A
Beta
N/A

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NYSE:OSTX) was last updated on 10/3/2025 by MarketBeat.com Staff
From Our Partners